Clinical Trial Update: Immune Response to Bivalent and Tetravalent Human Papillomavirus Vaccine in HIV Infected Adults [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating immune responses to bivalent and tetravalent HPV vaccines in HIV-infected adults has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Human Papillomavirus Infection

Drugs mentioned

• Cervarix (human papillomavirus vaccine, bivalent)
• Gardasil (human papillomavirus vaccine)

Snippet

Sponsor: University of Aarhus | Conditions: HIV, Human Papillomavirus | Phase 4 | Status: COMPLETED